A systematic review of thyroid dysfunction in preterm neonates exposed to topical iodine

Julie Aitken1, Fiona L R Williams

  • 1Population Health Sciences, Medical Research Institute, Mackenzie Building, University of Dundee, , Dundee, Scotland.

Insights

Neonatal exposure to iodine disinfectants can cause transient thyroid dysfunction in premature infants. Further research is needed to understand the long-term effects on neurodevelopment.

Area of Science:

  • Neonatal care
  • Endocrinology
  • Public Health

Background:

  • Premature infants (<32 weeks' gestation or <1.5 kg) are vulnerable to thyroid dysfunction.
  • Iodine exposure, both maternal and neonatal, is a potential risk factor.

Purpose of the Study:

  • To investigate the association between maternal or neonatal iodine exposure and transient thyroid dysfunction in high-risk neonates.
  • To synthesize evidence from existing studies on neonatal thyroid function following iodine exposure.

Main Methods:

  • A systematic review of electronic databases (Medline, Cochrane Library) was conducted.
  • Studies reporting neonatal thyroid function after topical iodine or maternal iodine exposure were included.
  • No restrictions were placed on publication date, study type, or language.

Main Results:

  • 15 studies were reviewed from an initial search of 794 papers.
  • Transient hypothyroidism/hyperthyrotropinemia occurred in 12-33% of neonates exposed to topical iodine, compared to 0% in unexposed infants.
  • Maternal iodine exposure data was not explicitly detailed in the results.

Conclusions:

  • Neonatal exposure to iodine-containing disinfectants is linked to thyroid dysfunction in preterm infants.
  • Current evidence does not address the impact of iodine exposure on neurodevelopment.
  • Restricting topical iodine disinfectant use in preterm infants and considering alternatives like chlorhexidine is recommended pending further research.
Abstract

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
52
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
59
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.2K
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
58
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
64
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
58